GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syndax Pharmaceuticals Inc (STU:1T3) » Definitions » Other Assets for Insurance Companies

Syndax Pharmaceuticals (STU:1T3) Other Assets for Insurance Companies


View and export this data going back to 2017. Start your Free Trial

What is Syndax Pharmaceuticals Other Assets for Insurance Companies?

Other Assets for Insurance Companies only applies to insurance companies.


Syndax Pharmaceuticals Business Description

Industry
Traded in Other Exchanges
Address
35 Gatehouse Drive, Building D, Floor 3, Waltham, MA, USA, 02451
Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.